Study chair Gabriel Brooks, MD, MPH, an Associate Professor of Medicine at the Dartmouth Geisel School of Medicine (IMAGE)

Alliance for Clinical Trials in Oncology

Study chair Gabriel Brooks, MD, MPH, an Associate Professor of Medicine at the Dartmouth Geisel School of Medicine

Caption

“Unplanned chemotherapy interruptions can be stressful, time consuming, and may affect how well treatment works,” said study chair Gabriel Brooks, MD, MPH, an Associate Professor of Medicine at the Dartmouth Geisel School of Medicine. “The PAGODA trial (Alliance A232402CD) will test a new approach that uses a clear, step-by-step plan to adjust chemotherapy doses before problems occur rather than waiting until side effects happen.”

Credit

Dartmouth Geisel School of Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.